• Easterbrook, P., Luhmann, N., Newman, M., Walsh, N., Lesi, O., Doherty, M., 2021. New WHO guidance for country validation of viral hepatitis B and C elimination. Lancet Gastroenterol. Hepatology 6, 778-780.

  • Kim, W. J., Okimoto, R. A., Purton, L. E., Goodwin, M., Haserlat, S. M., Dayyani, F., Sweetser, D. A., McClatchey, A. I., Bernard, O. A., Look, A. T. et al., 2008. Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood 111, 4716-4722.

  • Matsuzaka, Y., Tanihata, J., Ooshima, Y., Yamada, D., Sekiguchi, M., Miyatake, S., Aoki, Y., Terumitsu, M., Yashiro, R., Komaki, H. et al., 2020. The nSMase2/Smpd3 gene modulates the severity of muscular dystrophy and the emotional stress response in mdx mice. BMC Med. 18, 343.

  • Revill, K., Wang, T., Lachenmayer, A., Kojima, K., Harrington, A., Li, J., Hoshida, Y., Llovet, J. M., Powers, S., 2013. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. Gastroenterology 145, 1424-1435.

  • Soudani, N., Hage-Sleiman, R., Karam, W., Dbaibo, G., Zaraket, H., 2019. Ceramide suppresses influenza A virus replication in vitro. J. Virol. 93, e00053.-19.

  • Stoffel, W., Hammels, I., Jenke, B., Binczek, E., Schmidt-Soltau, I., Brodesser, S., Schauss, A., Etich, J., Heilig, J., Zaucke, F., 2016. Neutral sphingomyelinase (SMPD3) deficiency disrupts the Golgi secretory pathway and causes growth inhibition. Cell Death Dis. 7, e2488.

  • Teng, Y., Xu, Z., Zhao, K., Zhong, Y., Wang, J., Zhao, L., Zheng, Z., Hou, W., Zhu, C., Chen, X. et al., 2021. Novel function of SART1 in HNF4α transcriptional regulation contributes to its antiviral role during HBV infection. J. Hepatol. 75, 1072-1082.

  • Voisset, C., Lavie, M., Helle, F., Op, De Beeck A, Bilheu, A., Bertrand-Michel, J., Terce, F., Cocquerel, L., Wychowski, C., Vu-Dac, N. et al., 2008. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. Cell. Microbiol. 10, 606-617.

  • Wang, S., Chen, S., Sun, J., Han, P., Xu, B., Li, X., Zhong, Y., Xu, Z., Zhang, P., Mi, P. et al., 2023. m6A modification-tuned sphingolipid metabolism regulates postnatal liver development in male mice. Nat. Metab. 5, 842-860.

  • Xia, Y., Liang, T., 2019. Development of direct-acting antiviral and host-targeting agents for treatment of hepatitis B virus infection. Gastroenterology 156, 311-324.

  • Xia, Y., Guo, H., 2020. Hepatitis B virus cccDNA: formation, regulation and therapeutic potential. Antivir. Res. 180, 104824.

  • Xia, Y., Cheng, X., Nilsson, T., Zhang, M., Zhao, G., Inuzuka, T., Teng, Y., Li, Y., Anderson, D. E., Holdorf, M. et al., 2023. Nucleolin binds to and regulates transcription of hepatitis B virus covalently closed circular DNA minichromosome. Proc. Natl. Acad. Sci. U. S. A. 120, e2306390120.

  • Zhao, K., Liu, A., Xia, Y.,2020. Insights into hepatitis B virus DNA integration-55 years after virus discovery. Innovation (Camb.) 1, 100034.

  • Zhao, K., Wang, J., Wang, Z., Wang, M., Li, C., Xu, Z., Zhan, Q., Guo, F., Cheng, X., Xia, Y., 2025. Hepatitis B virus hijacks MRE11-RAD50-NBS1 complex to form its minichromosome. PLoS Pathog. 21, e1012824.

  • Zhou, W., Woodson, M., Sherman, M. B., Neelakanta, G., Sultana, H., 2019. Exosomes mediate Zika virus transmission through SMPD3 neutral sphingomyelinase in cortical neurons. Emerg. Microb. Infect. 8, 307-326.